Bonafide Health

We're very proud that Bonafide, along with our our Senior Director of Clinical Research, Trisha VanDusseldorp PhD, CSCS-D, FISSN, were included on this impressive list of Menopause Trailblazers. Bonafide will remain dedicated to exploring innovative ingredients and solutions backed by research to help provide women transitioning through menopause with a myriad of symptom management options that are safe, effective and clinically validated. #menopausematters #menopausehealth #perimenopause #menopause #womenshealth #womenshealthmatters #innovation

A great spotlight on Nargiza Dakmak, Bonafide's Director of eCommerce, and the work the team has done to customize the product review process for our customers. Check out the full case study, below. #innovation #personalization #ecommerce #digitalmarketing #womeninbusiness

Thank you, Nutraceuticals World, for including us in your piece on women's health and recent innovations in the dietary supplement space. This article includes a deep dive into the world of women's health supplements - covering the need for more research, investments and education, as well as discusses how we can continue to drive progress in this often neglected area of health and wellness. The piece also features thoughtful insights from Pharmavite's Vivian Sobral Rhoads, MegaFood's Sara Gragnolati, Tieraona Low Dog, MD and Bonafide Health's Kate Jamieson, among other thought leaders in the space. Check out the full article after the link: https://lnkd.in/e25XiCiW #womenshealth #supplements #innovation #womenshealthresearch #randd #womenshealthmatters #menopausehealth #sexualhealth #nutrition #wellness

Bonafide is proud to be a part of such an amazing organization that not only supports general health and wellness, but also prioritizes the importance of mental and emotional health and wellbeing.

On May 15th, 2024, Bonafide had the pleasure of hosting Mr. Makoto Inoue, President and Representative Director of Otsuka Pharmaceutical Co., Ltd. and Representative Director, COO of Otsuka Pharmaceutical Companies (U.S.) Holdings Co., Ltd. – parent company of Pharmavite, who recently acquired Bonafide Health in November of 2023 – at the company’s headquarters in Harrison, NY. Mr. Inoue’s visit served to inform Bonafide, the newest addition to Pharmavite’s growing portfolio of innovative women’s health brands, about future research plans, areas of focus and to identify strategic opportunities for global collaboration and expansion of the valuable synergies between the companies. We look forward to continuing to spearhead groundbreaking scientific studies and developing our growing suite of products to better support the increased demand for clinically backed products designed for supporting common women’s health needs. #innovation #vitaminsandsupplements #VMS #womenshealth #womenshealthmatters #menopause #perimenopause #RandD

Last week, Bonafide’s Senior Director of Clinical Research, Trisha VanDusseldorp PhD, CSCS-D, FISSN, participated in the Women of Wearables (wearables, health tech & femtech) Menopause 2.0 Global Conference – where she discussed the importance of scientific research and continued education for women in perimenopause and menopause. Here we include some of the highlights from the discussion.   We wanted to thank Women of Wearables for the opportunity to continue the conversation around this critically important subject and also celebrate the other participants on the panel including Abida Dhukai, Kathleen Jordan, MD, Stephanie Sassman and moderator, Maryon Stewart BEM, who are all doing amazing work to further spotlight menopause care and research.   #menopause #menopausehealth #researchanddevelopment #womenshealth #womenshealthmatters #perimenopause #clinicalresearch #innovation

In our 2023 State of Menopause Survey, we found that 79% of women think that self-education is the best way to navigate the menopause transition vs. relying solely on the healthcare system. This continues to ring true, and at Bonafide, we’ve remained dedicated to keeping women informed so they can feel empowered to advocate for better healthcare options during menopause and beyond. Here, Bonafide VP of Marketing and Ecommerce, Kate Jamieson speaks on this year's Expo West “Revolutionizing Women’s Health Supplements” panel, about just how important education can be during the menopausal journey. Check out the full clip below: https://lnkd.in/exBXAw2R And feel free to explore our Resource Center to access our growing library of expert reviewed content https://lnkd.in/dQZ6sApk. #menopause #menopauseinnovation #menopausehealth #womenshealth #womenshealthmatters #supplements #researchanddevelopment #RandD #expowest2024

Check out this interesting article from MDLinx on the topic of postponing menopause. Is it possible? And if so, what do you need to know? Featuring insights from Bonafide Chief Medical Officer, Dr. Alyssa Dweck - read more after the link: https://lnkd.in/egjYvdBK #menopause #menopausehealth #womenshealth #womenshealthmatters #innovation

Bonafide is looking forward to participating in the Women of Wearables (wearables, health tech & femtech) Menopause 2.0 conference on May 16th. Our Senior Director of Clinical Research, Trisha VanDusseldorp PhD, CSCS-D, FISSN, will be speaking about innovative solutions and research developments within the menopause and women's health space. #menopause #menopausehealth #researchanddevelopment #randd #womenshealth #womenshealthmatters

Bonafide® was excited to attend and sponsor the annual Society for Women's Health Research (SWHR) Awards Gala in Washington, D.C. this past Thursday – that honored Maria Shriver, Shontelle Dodson, PharmD and Janine Austin Clayton, MD, FARVO. Having supported the SWHR’s mission of transforming women's health through science, advocacy, and education in the past, Bonafide continues to seek new ways to contribute to the field of women’s health research, as well as to work with relevant organizations as a way to help further advance innovation and visibility within this space. Team members in attendance included Bonafide Health’s Kate Jamieson, Mallory Junggren and Lauren Tishkevich, and Pharmavite’s Ingrid Lebert and Peter Reinecke.